Archon Healthcare › Blog › Cancer Treatment
Interventional Oncology in China vs Chemotherapy — Key Differences for Bangladeshi Cancer Patients
Interventional oncology in China vs chemotherapy — 2026 guide for Bangladeshi cancer patients: how it differs, candidacy, costs, FAQs.
Short answer (as of October 2026): Chemotherapy travels through your whole body. Interventional oncology goes straight to the tumor. For Bangladeshi cancer patients exploring treatment in China, understanding interventional oncology in China vs chemotherapy is essential before choosing a plan. China's leading cancer hospitals — including centers in Guangzhou known for minimally invasive oncology — have built international reputations on image-guided tumor therapies that work locally,…
Chemotherapy travels through your whole body. Interventional oncology goes straight to the tumor. For Bangladeshi cancer patients exploring treatment in China, understanding interventional oncology in China vs chemotherapy is essential before choosing a plan. China's leading cancer hospitals — including centers in Guangzhou known for minimally invasive oncology — have built international reputations on image-guided tumor therapies that work locally, while conventional chemotherapy remains the systemic backbone of cancer care. As of October 2026, most Chinese oncology programs combine both approaches. This guide explains the key differences, when each is used, and what it costs.
Important: this article is general information, not medical advice. Your oncologist's treatment plan is specific to your cancer type and stage.
What Is Interventional Oncology?
Interventional oncology (IO) is a set of image-guided, minimally invasive procedures performed by interventional radiologists — usually through a small catheter in the groin or wrist, under CT or ultrasound guidance. Instead of circulating drugs through the entire bloodstream, IO delivers treatment directly to the tumor. The main techniques used in Chinese cancer hospitals include:
- TACE (transarterial chemoembolization): chemotherapy drugs injected directly into the tumor's feeding artery, then the artery is blocked — common for liver cancer
- RFA/Microwave ablation: heat probes destroy small tumors — liver, lung, kidney
- Cryoablation: freezing destroys tumor tissue while preserving surrounding structures
- NanoKnife (irreversible electroporation): electrical pulses kill tumor cells without heat, safer near blood vessels and bile ducts
- Radioembolization (Y-90): radioactive microspheres delivered through the hepatic artery
Learn more about cancer treatment options in China to see how these fit into a full treatment plan.
Key Differences: Interventional Oncology vs Chemotherapy
How They Attack Cancer
Chemotherapy is systemic: drugs circulate everywhere, attacking fast-dividing cells throughout the body — which is why hair loss, nausea, and immune suppression occur. Interventional oncology is local: the treatment concentrates at the tumor, largely sparing the rest of the body. This is why IO patients often keep their hair, appetite, and energy through treatment.
Side Effects and Recovery
Systemic chemotherapy side effects are well known — fatigue, vomiting, low blood counts, and weeks of recovery per cycle. IO procedures are typically done under local anesthesia with an overnight or 2–3 day hospital stay; most patients resume normal activity within a week. That said, IO is not side-effect-free: TACE can cause post-embolization fever and pain for several days, and any ablation carries bleeding or organ-injury risk.
Which Cancers Each Suits
Interventional oncology excels for localized tumors — liver cancer, early lung tumors, kidney tumors, and selected metastases. Chemotherapy remains essential for widespread or metastatic disease, blood cancers like leukemia, and as a partner to surgery and radiation. As of October 2026, Chinese oncology teams most often recommend combination therapy: IO for the main tumor mass plus systemic chemotherapy or immunotherapy to handle microscopic spread.
Costs in China — 2026 Estimates
Costs vary by hospital, tumor, and the number of sessions needed. As of October 2026, indicative estimates are:
- Single TACE or ablation session: roughly USD 4,000–10,000 (~BDT 480,000–1,200,000)
- NanoKnife session: roughly USD 8,000–15,000 (~BDT 960,000–1,800,000)
- Chemotherapy cycle (per cycle): roughly USD 1,500–5,000 (~BDT 180,000–600,000), depending on the drug regimen — most protocols need 4–8 cycles
- Combined treatment plan: roughly USD 15,000–40,000 (~BDT 1,800,000–4,800,000) for a full course
These are treatment estimates and exclude travel, accommodation, and follow-up. Because Chinese hospitals price by procedure rather than by package in many cases, request an itemized written estimate for your specific case before travel — our transparent costing support helps Bangladeshi patients get clarity from hospitals directly.
Frequently Asked Questions
Can interventional oncology replace chemotherapy completely?
As of October 2026, only for selected early-stage, localized tumors. For most cancers, Chinese oncologists recommend combining IO with systemic therapy. A hospital that promises IO alone can cure advanced metastatic cancer is making a claim no honest oncologist would make.
How long must I stay in China for interventional oncology?
As of October 2026, a single IO session typically requires 1–2 weeks in China including workup and observation; multi-session plans (TACE repeated monthly, or IO plus chemotherapy cycles) extend stays to 4–8 weeks. Confirm the session count and schedule in writing before booking flights.
Is interventional oncology available in Bangladesh?
As of October 2026, basic ablation and embolization exist in a few Bangladeshi centers, but the full interventional oncology toolkit — NanoKnife, Y-90, and high-volume IO experience — is a key reason patients travel to China's specialized cancer hospitals.
What documents do Chinese hospitals need to recommend a plan?
As of October 2026, recent imaging (CT/MRI with DICOM files), biopsy pathology reports, blood work, and a summary of prior treatments. Chinese oncology teams review these remotely and propose a treatment plan with costs before you apply for your visa.
How Archon Healthcare Can Help
Archon Healthcare is Bangladesh's trusted bridge to world-class hospitals in China, Pakistan, Korea, Thailand, and beyond. For cancer patients, we arrange remote case reviews with Chinese oncology teams, obtain written treatment plans and itemized cost estimates, coordinate medical visa assistance for China, and plan your travel and accommodation around your treatment schedule.
Complete support beyond the hospital — in any country: Archon Healthcare does not stop at hospital referrals. Wherever your treatment takes you — Pakistan, China, Thailand, South Korea, Singapore, or any other country — we also arrange the practical side of the journey for our patients and their families:
- Trip arrangements — end-to-end planning of your medical trip, from schedule to return.
- Accommodation — comfortable stays near your hospital for the patient and attendants.
- Transportation & rides — airport pickup and local transport for hospital visits and follow-ups.
One team coordinates your treatment and your travel, so you can focus only on getting better.
📩 Contact us: info@archonhc.com
🌐 Website: archonhc.com
Explore Archon Healthcare
- Your patient journey in six steps — from first message to follow-up care back in Dhaka.
- Partner hospitals — Modern Cancer, Gil, Bayındır and Zhujiang.
- Partner with us — hospitals, clinics, corporates and referral partners.
- Archon Healthcare home — treatment areas, destinations and the Find Your Treatment Path tool.
Related articles
Ready to start?
It begins with a simple message — send your reports or just describe your case.
